HLS 10RS-1209 ORIGINAL
Page 1 of 2
CODING: Words in struck through type are deletions from existing law; words underscored
are additions.
Regular Session, 2010
HOUSE BILL NO. 1073
BY REPRESENTATIVE MILLS
PHARMACISTS: Provides with respect to drugs of concern in the prescription monitoring
program
AN ACT1
To enact R.S. 40:1005(D) and (E), relative to the Prescription Monitoring Program; to2
provide for drugs of concern; to provide for a timeline; to provide for reports and3
recommendations; and to provide for related matters.4
Be it enacted by the Legislature of Louisiana:5
Section 1. R.S. 40:1005(D) and (E) are hereby enacted to read as follows: 6
ยง1005. Advisory council ; recommendations for drugs of concern7
* * *8
D. Once a drug has been declared by the board to be a drug of concern, the9
board shall have one year from the date of declaration to collect data on the drug,10
make an assessment, and issue a report to the House and Senate committees on11
health and welfare recommending one of the following:12
(1) That the drug be declared a controlled dangerous substance pursuant to13
R.S. 40:961 et seq.14
(2) That the drug be removed from the list as a drug of concern.15
E. In the event that, after one year, the board cannot make a determination16
regarding a drug of concern as provided by Subsection D of this Section, the board17
shall issue a report to the House and Senate committees on health and welfare18
requesting more time for data collection and advising when a subsequent report with19 HLS 10RS-1209 ORIGINAL
HB NO. 1073
Page 2 of 2
CODING: Words in struck through type are deletions from existing law; words underscored
are additions.
recommendations pursuant to Subsection D of this Section shall be submitted to the1
committees.2
* * *3
DIGEST
The digest printed below was prepared by House Legislative Services. It constitutes no part
of the legislative instrument. The keyword, one-liner, abstract, and digest do not constitute
part of the law or proof or indicia of legislative intent. [R.S. 1:13(B) and 24:177(E)]
Mills HB No. 1073
Abstract: Provides relative to the Prescription Monitoring Program. Provides that once a
drug is deemed by the La. Board of Pharmacy to be a drug of concern, the board, in
consultation with the advisory council, shall have a year to gather data on the drug
and make a recommendation in a report to the House Committee on Health and
Welfare and the Senate Committee on Health and Welfare as to whether or not the
drug should be declared a controlled dangerous substance or removed from the list
as a drug of concern. If the board determines there is not enough information to make
a recommendation after one year, the board may conduct further study and issue a
later report of recommendations.
Present law provides that the La. Board of Pharmacy shall seek, and the advisory council of
the Prescription Monitoring Program shall provide, information and advice regarding which
drugs of concern should be monitored.
Proposed law retains present law but adds that once a drug has been deemed by the board
to be a drug of concern, the board, in consultation with the advisory council shall have one
year from the date of declaration to collect data on the drug, make an assessment, and issue
a report to the House and Senate Committees on Health and Welfare as to whether or not the
drug should be declared a controlled dangerous substance or removed from the list as a drug
of concern.
Proposed law provides that if the La. Board of Pharmacy is unable to make a determination
after one year whether or not a drug should be declared a controlled dangerous substance or
removed from the list of drugs of concern, the board shall submit a report to the House and
Senate Committees on Health and Welfare requesting more time for data collection and
advising when a subsequent report with recommendations shall be submitted.
(Adds R.S. 40:1005(D) and (E))